deltatrials
Completed PHASE3 INTERVENTIONAL 1-arm NCT04224194

Auto-injector Real Life Handling in Patients

Assessment of Real-life Patient Handling Experience of AVT02 Administered Subcutaneous With an Auto-Injector in Patients With Moderate to Severe Active RA

Sponsor: Alvotech Swiss AG

Conditions RA
Interventions Adalimumab
Updated 9 times since 2020 Last updated: Apr 29, 2022 Started: Nov 4, 2019 Primary completion: Jul 8, 2020 Completion: Feb 26, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04224194, this PHASE3 trial focuses on RA and remains completed. Sponsored by Alvotech Swiss AG, it has been updated 9 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Feb 2020 – ~Jun 2020 · 4 months · monthly snapshot~Jun 2020 – ~Aug 2020 · 2 months · monthly snapshot~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshotActive Not Recruiting~Sep 2021 – ~Jun 2022 · 9 months · monthly snapshotCompleted~Jun 2022 – ~Jul 2024 · 25 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 12 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Jun 2022 — Jul 2024 [monthly]

    Completed PHASE3

  5. Sep 2021 — Jun 2022 [monthly]

    Completed PHASE3

    Status: Active Not Recruiting → Completed

▶ Show 4 earlier versions

  1. Jan 2021 — Sep 2021 [monthly]

    Active Not Recruiting PHASE3

  2. Aug 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE3

  3. Jun 2020 — Aug 2020 [monthly]

    Active Not Recruiting PHASE3

    Status: Recruiting → Active Not Recruiting

  4. Feb 2020 — Jun 2020 [monthly]

    Recruiting PHASE3

    First recorded

Nov 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Alvotech Swiss AG
Data source: Alvotech Swiss AG

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations